Clinical Trial Update: AZD2066 Neuropathic Pain - Mechanical Hypersensitivity [Phase 2]

View source ↗

Summary

A Phase 2 trial of AZD2066 for neuropathic pain with mechanical hypersensitivity was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• AZD2066 (AZD2066)

Snippet

Sponsor: AstraZeneca | Conditions: Neuropathic Pain, Mechanical Hypersensitivity | Phase 2 | Status: TERMINATED | Results posted: 2012-09-27